105 related articles for article (PubMed ID: 23875616)
21. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
23. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
[TBL] [Abstract][Full Text] [Related]
24. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
25. Multivariate analysis for the optimization of microfluidics-assisted nanoprecipitation method intended for the loading of small hydrophilic drugs into PLGA nanoparticles.
Chiesa E; Dorati R; Modena T; Conti B; Genta I
Int J Pharm; 2018 Jan; 536(1):165-177. PubMed ID: 29175645
[TBL] [Abstract][Full Text] [Related]
26. Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation.
Ali ME; Lamprecht A
Int J Pharm; 2013 Nov; 456(1):135-42. PubMed ID: 23958752
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
29. Optimization of maghemite-loaded PLGA nanospheres for biomedical applications.
Silva MF; Winkler Hechenleitner AA; de Oliveira DM; Agüeros M; Peñalva R; Irache JM; Pineda EA
Eur J Pharm Sci; 2013 Jun; 49(3):343-51. PubMed ID: 23602998
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent.
Wang CW; Yang SP; Hu H; Du J; Li FH
Mol Med Rep; 2015 Mar; 11(3):1885-90. PubMed ID: 25394467
[TBL] [Abstract][Full Text] [Related]
31. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
[TBL] [Abstract][Full Text] [Related]
32. Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination.
Osman R; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
Int J Pharm; 2011 Apr; 408(1-2):257-65. PubMed ID: 21335080
[TBL] [Abstract][Full Text] [Related]
33. Statistical analysis of low molecular mass heparin nanoencapsulation.
Ganti V; Mengesha AE; Marszalek J; Youan BB
Acta Pharm; 2010 Sep; 60(3):281-93. PubMed ID: 21134863
[TBL] [Abstract][Full Text] [Related]
34. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
36. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
37. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
38. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
[TBL] [Abstract][Full Text] [Related]
39. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
Cohen-Sela E; Chorny M; Koroukhov N; Danenberg HD; Golomb G
J Control Release; 2009 Jan; 133(2):90-5. PubMed ID: 18848962
[TBL] [Abstract][Full Text] [Related]
40. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel.
Manoochehri S; Darvishi B; Kamalinia G; Amini M; Fallah M; Ostad SN; Atyabi F; Dinarvand R
Daru; 2013 Jul; 21(1):58. PubMed ID: 23866721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
